patients with newly diagnosed multiple myeloma were randomly allotted to an intermittent high-dose melphalan/prednisone ( mp ) treatment ( 120 patients ) or a continuous low-dose melphalan ( m ) regimen ( 99 patients ) .
C0284383
melphalan/prednisone
C0025241
melphalan